A North Hills woman is the first to receive a new vaccine for early-stage breast cancer.
Magee Women's Hospital and The Hillman Cancer Center have been working together to develop a vaccine for people with early stage breast cancer.
Dr. Natalie Gentile, Direct Care Physician tells the Big K Morning Show how significant this will be for everybody around the world.
“With this research, as a primary care physician, I am unfortunately seeing more and more breast cancer being diagnosed and in younger and younger women and to have the opportunity to someday that we could be preventing progression to invasive disease is very exciting,” said Gentile.
when asked about the clinical trial and how long it lasts, Dr. Gentile explains, “for years and years at a time, because there’s multiple doses of these vaccines typically and then they’re trying to assess if there’s progression of disease, specifically in this clinical trial, to invasive breast cancer.”
About one in five new breast cancers will be diagnosed as DCIS, which is the earliest form of breast cancer and can be detected in a mammogram.
Gentile says if proven effective, it then has to gain regulatory.